You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The study also found that younger African-Americans who received genomic testing were more likely to be treated with chemotherapy even with low assay scores.
CMS issued its final Clinical Laboratory Fee Schedule for 2016 yesterday, shifting to gapfill rather crosswalk new codes as initially proposed for MAAAs.
Researchers considered the management impact of multigene panel results for more than 1,000 BRCA1/2 mutation-free women referred for hereditary breast and ovarian cancer testing.
This article has been updated to clarify CMS's initial determination on the reimbursement process for AMA's new molecular pathology test codes.
NEW YORK (GenomeWeb News) - Transgenomic today said that it has signed a definitive agreement to acquire the global rights to a multi-gene prognostic test for scoliosis from Axial Biotech.
The funding is part of an initiative led by the UK's Technology Strategy Board to develop tools for tumor profiling and data capture.
The deal is a "strategic move into gastrointestinal diagnostics," and will accelerate development of diagnostics in oncology and possibly other therapeutic areas.
The company said that Aetna has determined that AlloMap is medically necessary for monitoring rejection in heart transplant recipients more than a year after a heart transplant.
Signal filed its suit against Med BioGene earlier this month alleging a breach of agreement, violation of a confidentiality agreement, and misuse of proprietary information, among other charges.
Signal has alleged that Med BioGene breached the provisions in a term sheet inked between the two companies regarding an exclusive, worldwide license for Med BioGene's LungExpress Dx test.
The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.
According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.
The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.
In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.